Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11593)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 7, 2015 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kanda M, Sugimoto H, Kodera Y. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World J Gastroenterol 2015; 21(37): 10584-10597 [PMID: 26457018 DOI: 10.3748/wjg.v21.i37.10584] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i37/10584.htm |
| Number | Citing Articles |
| 1 |
Jing Wang, Shuzhi Wu, Tianren Huang. Expression and role of VEGFA and miR‑381 in portal vein tumor thrombi in patients with hepatocellular carcinoma. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6129
|
| 2 |
Britta Laube, Sandra Michaelsen, Veronika Meischner, Andrea Hartwig, Bernd Epe, Michael Schwarz. Classification or non-classification of substances with positive tumor findings in animal studies: Guidance by the German MAK commission. Regulatory Toxicology and Pharmacology 2019; 108: 104444 doi: 10.1016/j.yrtph.2019.104444
|
| 3 |
Hui Li, Huicheng Chen, Haibin Wang, Yilong Dong, Min Yin, Liang Zhang, Jia Wei. MicroRNA-374a Promotes Hepatocellular Carcinoma Cell Proliferation by Targeting Mitogen-Inducible Gene 6 (MIG-6). Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(4): 557 doi: 10.3727/096504017X15000784459799
|
| 4 |
Yan-Yan Jia, Jin-Yi Zhao, Bing-Ling Li, Kai Gao, Ying Song, Mei-You Liu, Xiao-Juan Yang, Yan Xue, Ai-Dong Wen, Lei Shi. miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth. Oncotarget 2016; 7(23): 35257 doi: 10.18632/oncotarget.9135
|
| 5 |
Meng Pu, Jianlin Wang, Qike Huang, Ge Zhao, Congcong Xia, Runze Shang, Zhuochao Zhang, Zhenyuan Bian, Xishegn Yang, Kaishan Tao. High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes. Tumor Biology 2017; 39(7): 101042831770912 doi: 10.1177/1010428317709127
|
| 6 |
Rong Chen, Meng Zhao, Yanli An, Dongfang Liu, Qiusha Tang. GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11107-7
|
| 7 |
Guadalupe S. López-Álvarez, Tomasz K. Wojdacz, Claudia M. García-Cuellar, Hugo C. Monroy-Ramírez, Miguel A. Rodríguez Segura, Ruth A. Pacheco Rivera, Carlos A. Valencia-Antúnez, Nancy C. Cervantes-Anaya, Ernesto Soto-Reyes, Verónica R. Vázquez-Garzón, Yesennia Sánchez-Pérez, Saúl Villa Treviño. Gene silencing of Nox4 by CpG island methylation during hepatocarcinogenesis in rats. Biology Open 2016; doi: 10.1242/bio.020370
|
| 8 |
Dai Shimizu, Mitsuro Kanda, Hiroyuki Sugimoto, Masahiro Shibata, Haruyoshi Tanaka, Hideki Takami, Naoki Iwata, Masamichi Hayashi, Chie Tanaka, Daisuke Kobayashi, Suguru Yamada, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Tsutomu Fujii, Yasuhiro Kodera. The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy. International Journal of Oncology 2017; 50(2): 381 doi: 10.3892/ijo.2017.3833
|
| 9 |
Xiaoming Liu, Xingyu Chen, Mengqing Xiao, Yuxing Zhu, Renjie Gong, Jianye Liu, Qinghai Zeng, Canxia Xu, Xiong Chen, Fen Wang, Ke Cao. RANBP2 Activates O-GlcNAcylation through Inducing CEBPα-Dependent OGA Downregulation to Promote Hepatocellular Carcinoma Malignant Phenotypes. Cancers 2021; 13(14): 3475 doi: 10.3390/cancers13143475
|
| 10 |
Chieh-Hsiang Chan, Chun-Ming Chen, Yan-Hwa Wu Lee, Li-Ru You. DNA Damage, Liver Injury, and Tumorigenesis: Consequences of DDX3X Loss. Molecular Cancer Research 2019; 17(2): 555 doi: 10.1158/1541-7786.MCR-18-0551
|
| 11 |
Umaira Zakir, Nadir Naveed Siddiqui, Faizan-ul-Hassan Naqvi, Rizma Khan. Aberrant STAT1 methylation as a non-invasive biomarker in blood of HCV induced hepatocellular carcinoma. Cancer Biomarkers 2022; 34(1): 95 doi: 10.3233/CBM-210216
|
| 12 |
Xin Qing, Wenjing Xu, Jingjing Zong, Xuanlong Du, Hao Peng, Yewei Zhang. Emerging treatment modalities for systemic therapy in hepatocellular carcinoma. Biomarker Research 2021; 9(1) doi: 10.1186/s40364-021-00319-3
|
| 13 |
Mitsuro Kanda, Yasuhiro Kodera. Molecular mechanisms of peritoneal dissemination in gastric cancer. World Journal of Gastroenterology 2016; 22(30): 6829-6840 doi: 10.3748/wjg.v22.i30.6829
|
| 14 |
Aimei Liu, Qinghua Wu, Dapeng Peng, Irma Ares, Arturo Anadón, Bernardo Lopez‐Torres, María‐Rosa Martínez‐Larrañaga, Xu Wang, María‐Aránzazu Martínez. A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation. Medicinal Research Reviews 2020; 40(5): 1973 doi: 10.1002/med.21696
|
| 15 |
Henrik H. Hansen, Susanne Pors, Maja W. Andersen, Mogens Vyberg, Jacob Nøhr-Meldgaard, Malte Hasle Nielsen, Denise Oró, Martin Rønn Madsen, Monika Lewinska, Mathias B. Møllerhøj, Andreas Nygaard Madsen, Michael Feigh. Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-50328-5
|
| 16 |
Yonghao Liang, Qisheng Li, Keli Chen, Wen Ni, Zetao Zhan, Feng Ye, Yiyi Li, Yuan Fang, Fengjiao Zhang, Longhua Chen, Yi Ding. Zinc finger protein 307 functions as a tumor-suppressor and inhibits cell proliferation by inducing apoptosis in hepatocellular carcinoma. Oncology Reports 2017; 38(4): 2229 doi: 10.3892/or.2017.5868
|
| 17 |
Lili Cao, Lijun Zhang, Xiang Zhao, Ye Zhang, Daolin Tang. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells. PLOS ONE 2016; 11(8): e0161025 doi: 10.1371/journal.pone.0161025
|
| 18 |
Shinichi Umeda, Mitsuro Kanda, Yasuhiro Kodera. Recent advances in molecular biomarkers for patients with hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2019; 19(8): 725 doi: 10.1080/14737159.2019.1638254
|
| 19 |
Xiu-Yan Huang, Zi-Li Huang, Yong-Hua Xu, Qi Zheng, Zi Chen, Wei Song, Jian Zhou, Zhao-You Tang, Xin-Yu Huang. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-05432-8
|
| 20 |
Tianxin Xu, Jie Yuan, Fei Song, Nannan Zhang, Cheng Gao, Zhong Chen. Exploring the functional role of tRF-39-8HM2OSRNLNKSEKH9 in hepatocellular carcinoma. Heliyon 2024; 10(5): e27153 doi: 10.1016/j.heliyon.2024.e27153
|
| 21 |
Satoko Umetsu, Hiroki Mizukami, Takeshi Saito, Chiaki Uchida, Akiko Igawa, Kazuhiro Kudo, Chieko Itabashi, Sho Osonoi, Guo Danyang, Takanori Sasaki, Soroku Yagihashi, Kenichi Hakamada. Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-57883-1
|
| 22 |
Jia-Cheng Tang, Yi-Li Feng, Tao Guo, An-Yong Xie, Xiu-Jun Cai. Circulating tumor DNA in hepatocellular carcinoma: trends and challenges. Cell & Bioscience 2016; 6(1) doi: 10.1186/s13578-016-0100-z
|
| 23 |
Ci Song, Yao Liu, Lu Xu, Juan Wen, Deke Jiang, Jianguo Chen, Xiangjun Zhai, Zhibin Hu, Li Liu, Jibin Liu. Hepatitis B virus mutations, expression quantitative trait loci for PTPN12, and their interactions in hepatocellular carcinoma. Cancer Medicine 2016; 5(7): 1687 doi: 10.1002/cam4.712
|
| 24 |
Yue-Li Nan, Yan-Ling Hu, Zhi-Ke Liu, Fang-Fang Duan, Yang Xu, Shu Li, Ting Li, Da-Fang Chen, Xiao-Yun Zeng. Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(24): 5558-5567 doi: 10.3748/wjg.v22.i24.5558
|
| 25 |
Bin Zheng, MS, Heng Wang, MS, Jin-xue Wang, MS, Zheng-hong Liu, MS, Pu Zhang, MD, Dahong Zhang, MD. The Clinical Significance of RMI2 in Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2021; 20: 153303382110454 doi: 10.1177/15330338211045496
|
| 26 |
Chinthalapally V. Rao, Adam S. Asch, Hiroshi Y. Yamada. Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer. Carcinogenesis 2017; 38(1): 2 doi: 10.1093/carcin/bgw118
|
| 27 |
Nadia Panera, Annalisa Crudele, Ilaria Romito, Daniela Gnani, Anna Alisi. Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2017; 18(1): 99 doi: 10.3390/ijms18010099
|
| 28 |
Qin Tang, Qi Wang, Qiong Zhang, Sheng-Yan Lin, Yanhong Zhu, Xiangliang Yang, An-Yuan Guo. Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3860-x
|
| 29 |
Man Wu, Xueqing Xia, Jiemiao Hu, Natalie Wall Fowlkes, Shulin Li. WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-23864-9
|
| 30 |
Qiwei Yao, Yilin Yu, Zhiping Wang, Mengyan Zhang, Jiayu Ma, Yahua Wu, Qunhao Zheng, Jiancheng Li. CANT1 serves as a potential prognostic factor for lung adenocarcinoma and promotes cell proliferation and invasion in vitro. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09175-2
|
| 31 |
Leilei Niu, Liping Liu, Shengli Yang, Jianwei Ren, Paul B.S. Lai, George G. Chen. New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017; 1868(2): 564 doi: 10.1016/j.bbcan.2017.10.002
|
| 32 |
Shinichi Umeda, Mitsuro Kanda, Hiroyuki Sugimoto, Haruyoshi Tanaka, Masamichi Hayashi, Suguru Yamada, Tsutomu Fujii, Hideki Takami, Yukiko Niwa, Naoki Iwata, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Yasuhiro Kodera. Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3629-2
|
| 33 |
Yan Wang, Mengjing Sun, Jibin Liu, Ying Liu, Chunyi Jiang, Huijun Zhu, Wei Wang, Yao Wang. FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.11183
|
| 34 |
Xiaolong Liu, Xiaotong Hu, Yeye Kuang, Peijian Yan, Lili Li, Chen Li, Qian Tao, Xiujun Cai. BCLB, methylated in hepatocellular carcinoma, is a starvation stress sensor that induces apoptosis and autophagy through the AMPK-mTOR signaling cascade. Cancer Letters 2017; 395: 63 doi: 10.1016/j.canlet.2017.02.030
|
| 35 |
Mitsuro Kanda, Dai Shimizu, Haruyoshi Tanaka, Masahiro Shibata, Naoki Iwata, Masamichi Hayashi, Daisuke Kobayashi, Chie Tanaka, Suguru Yamada, Tsutomu Fujii, Goro Nakayama, Hiroyuki Sugimoto, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer. Oncotarget 2016; 7(12): 13667 doi: 10.18632/oncotarget.7269
|
| 36 |
Jonathan Choiniere, Jianguo Wu, Li Wang. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins. Molecular Pharmacology 2017; 91(3): 189 doi: 10.1124/mol.116.106757
|
| 37 |
Nan Cheng, Ju Wu, Min Yin, Jian Xu, Yadong Wang, Xi Chen, Zhequn Nie, Jiajun Yin. LncRNA CASC11 promotes cancer cell proliferation in hepatocellular carcinoma by inhibiting miRNA-188-5p. Bioscience Reports 2019; 39(4) doi: 10.1042/BSR20190251
|
| 38 |
Fengjie Xu, Runzhui Lin, Jianrui Liu, Zeming Chen, Hua Zhuo, Xingmu Liu, Dong-Hua Yang. Intravenous Immunoglobulin Inhibits Liver Cancer Progression by Promoting p38MAPK-Associated Apoptosis. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/1300989
|
| 39 |
Mitsuro Kanda, Kenta Murotani, Hiroyuki Sugimoto, Takashi Miwa, Shinichi Umeda, Masaya Suenaga, Masamichi Hayashi, Norifumi Hattori, Chie Tanaka, Daisuke Kobayashi, Suguru Yamada, Michitaka Fujiwara, Yasuhiro Kodera. An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma. Oncotarget 2017; 8(41): 71070 doi: 10.18632/oncotarget.20369
|
| 40 |
Fang Wang, Peter Breslin S J, Wei Qiu. Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma. Liver Research 2021; 5(4): 195 doi: 10.1016/j.livres.2021.06.001
|
| 41 |
Bolin Wu, Xitian Liang, Hui Jing, Xue Han, Yixin Sun, Cunli Guo, Ying Liu, Wen Cheng. Effect of NET-1 siRNA conjugated sub-micron bubble complex combined with low-frequency ultrasound exposure in gene transfection. Oncotarget 2018; 9(3): 4150 doi: 10.18632/oncotarget.23646
|
| 42 |
Fu-Biao Ni, Zhuo Lin, Xu-Hui Fan, Ke-Qing Shi, Jian-Yang Ao, Xiao-Dong Wang, Rui-Cong Chen. A novel genomic-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma. Clinica Chimica Acta 2020; 504: 88 doi: 10.1016/j.cca.2020.02.001
|
| 43 |
Yuting Wu, Yingshi Zhang, Xiaochun Qin, Haobin Geng, Daiying Zuo, Qingchun Zhao. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharmacological Research 2020; 160: 105195 doi: 10.1016/j.phrs.2020.105195
|
| 44 |
Ying Liu, Xiaoqin Wei, Xinrui Zhang, Caifeng Pang, Mingkai Xia, Yong Du. CT radiomics combined with clinical variables for predicting the overall survival of hepatocellular carcinoma patients after hepatectomy. Translational Oncology 2022; 26: 101536 doi: 10.1016/j.tranon.2022.101536
|
| 45 |
Cheng Guo, Jie Zhou, Boyu Ma, Rui Wang, Yanli Ge, Zhe Wang, Bing Ji, Wei Wang, Junjie Zhang, Zhirong Wang. A Somatic Mutation-Derived LncRNA Signature of Genomic Instability Predicts Prognosis for Patients With Liver Cancer. Frontiers in Surgery 2021; 8 doi: 10.3389/fsurg.2021.724792
|
| 46 |
Zhiyu Ye, Xudong Chen, Xiaogang Chen. ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition. Oncology Letters 2017; doi: 10.3892/ol.2017.7453
|